Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?
Clinical trial NCT02520518 · TERMINATED
Trial details
- NCT number
- NCT02520518
- Sponsor
- Christopher Bell
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.